$NVTA

Invitae Corp

  • NEW YORK STOCK EXCHANGE INC.
  • Health Services
  • Medical/Nursing Services
  • Health Care and Social Assistance
  • Medical Laboratories

PRICE

$1.22 β–²1.667%

Extented Hours

VOLUME

3,822,702

DAY RANGE

1.14 - 1.21

52 WEEK

1.02 - 9

Join Discuss about NVTA with like-minded investors

profile
@singletary #StockTraders.NET
recently

reminds me on $NVTA so make sure to hit under key lvls. not adding above

77 Replies 15 πŸ‘ 10 πŸ”₯

profile
@Chano #StockTraders.NET
recently

$NVTA bounce day

66 Replies 10 πŸ‘ 14 πŸ”₯

profile
@singletary #StockTraders.NET
recently

can not be a rider and oh its almost top. $SIGA $VERU $BBBY $NVTA all will end you

135 Replies 15 πŸ‘ 6 πŸ”₯

profile
@Chano #StockTraders.NET
recently

I fucked up on NVTA today is the quiet fade day, I was waiting for a morning push to smack it

51 Replies 12 πŸ‘ 7 πŸ”₯

profile
@Navneet #droscrew
recently

$nvta 5.5 calls 9/16 1.15

108 Replies 15 πŸ‘ 10 πŸ”₯

SO
@soheil.n #StockTraders.NET
recently

all out $NVTA ...

86 Replies 12 πŸ‘ 7 πŸ”₯

profile
@Chano #StockTraders.NET
recently

$NVTA those covers again! πŸ₯΄

127 Replies 9 πŸ‘ 8 πŸ”₯

SO
@soheil.n #StockTraders.NET
recently

watching $NVTA

57 Replies 12 πŸ‘ 6 πŸ”₯

profile
@Chano #StockTraders.NET
recently

early covers is my superpower! $NVTA

115 Replies 7 πŸ‘ 7 πŸ”₯

profile
@CarlosH-carvan #ivtrades
recently

$NVTA $6.61 to go

98 Replies 14 πŸ‘ 8 πŸ”₯

profile
@CarlosH-carvan #ivtrades
recently

yup > @cespinoza9801 said: $nvta again lol

67 Replies 8 πŸ‘ 14 πŸ”₯

profile
@cespinoza9801 #ivtrades
recently

$nvta again lol

129 Replies 8 πŸ‘ 12 πŸ”₯

profile
@singletary #StockTraders.NET
recently

careful chasing any. after NVTA many will actually fail this time

53 Replies 9 πŸ‘ 10 πŸ”₯

profile
@singletary #StockTraders.NET
recently

question is on $NVTA is does the daily end up like $AMTD

84 Replies 9 πŸ‘ 13 πŸ”₯

profile
@Chano #StockTraders.NET
recently

missed the whole damn thing for not taking a starter in the PM it was down too much already > @singletary said: $NVTA nice halt.

49 Replies 11 πŸ‘ 6 πŸ”₯

profile
@singletary #StockTraders.NET
recently

$NVTA nice halt.

68 Replies 10 πŸ‘ 12 πŸ”₯

profile
@Chano #StockTraders.NET
recently

did you develop a plan or an idea on $NVTA?

149 Replies 9 πŸ‘ 9 πŸ”₯

profile
@Math #StockTraders.NET
recently

$NVTA shorts never got a chance to get in post squeeze on SSR fail

91 Replies 11 πŸ‘ 7 πŸ”₯

profile
@Chano #StockTraders.NET
recently

I have NVTA on watch, bag holders should be there by now

79 Replies 8 πŸ‘ 7 πŸ”₯

profile
@singletary #StockTraders.NET
recently

7.69 lvl then 7.2 nxt lvl $NVTA

66 Replies 8 πŸ‘ 11 πŸ”₯

profile
@dros #droscrew
recently

RECAP 8/10 +Pos Comments: $INKT + HC Wainwright RECAP 8/10 -Neg Comments: $COIN - CFRA $BLI - MS $NVTA - JPM $BLDP - RayJay $OPFI - DA Davidson

121 Replies 12 πŸ‘ 6 πŸ”₯

DA
@danny4259 #StockTraders.NET
recently

I had to run an errand today, came back near the close and I was able to short into the parabolic move over 8.5s. Knew it was still front side so I covered into the pullback. What a crazy runner $NVTA was today. Hope everyone stayed safe.

137 Replies 6 πŸ‘ 13 πŸ”₯

profile
@Navneet #droscrew
recently

$nvta holy shit

103 Replies 6 πŸ‘ 10 πŸ”₯

SO
@soheil.n #StockTraders.NET
recently

$NVTA - hogging the 10 EMA on 1 min chart

105 Replies 7 πŸ‘ 15 πŸ”₯

profile
@Chano #StockTraders.NET
recently

I have a 20 SMA and the turd bounced there numerous times to the penny $NVTA

140 Replies 14 πŸ‘ 9 πŸ”₯

profile
@Chano #StockTraders.NET
recently

$NVTA behaving like a way smaller float

141 Replies 12 πŸ‘ 7 πŸ”₯

profile
@singletary #StockTraders.NET
recently

$NVTA we have got the fail a few times. just never the failed follow thru

99 Replies 15 πŸ‘ 14 πŸ”₯

profile
@singletary #StockTraders.NET
recently

$NVTA nutso i like it here 5.5

117 Replies 15 πŸ‘ 6 πŸ”₯

profile
@cespinoza9801 #ivtrades
recently

$nvta over 100% lol

146 Replies 8 πŸ‘ 13 πŸ”₯

profile
@singletary #StockTraders.NET
recently

time of day not ideal for me $NVTA will wait tomm

63 Replies 11 πŸ‘ 8 πŸ”₯

SO
@soheil.n #StockTraders.NET
recently

grrr...why do i just watch $NVTA just to go higher and not long it ...so i can short it for peanuts πŸ€¦β€β™‚οΈ

145 Replies 13 πŸ‘ 10 πŸ”₯

profile
@singletary #StockTraders.NET
recently

$NVTA you can see how 4.01 is the new 3.45. very clean on the charts/wicks

83 Replies 7 πŸ‘ 11 πŸ”₯

SO
@soheil.n #StockTraders.NET
recently

keep in mind has over 81% IO and high short float 22% > @singletary said: great warning $NVTA hope all stayed safe. now can wait for edge

111 Replies 13 πŸ‘ 14 πŸ”₯

profile
@singletary #StockTraders.NET
recently

great warning $NVTA hope all stayed safe. now can wait for edge

126 Replies 8 πŸ‘ 12 πŸ”₯

profile
@singletary #StockTraders.NET
recently

$NVTA watchout

111 Replies 13 πŸ‘ 13 πŸ”₯

SO
@soheil.n #StockTraders.NET
recently

$NVTA - vol is building around 3.75...ideal for a big push to trap longs and then unwind

135 Replies 7 πŸ‘ 14 πŸ”₯

SO
@soheil.n #StockTraders.NET
recently

have you traded this yet from the para? > @singletary said: $NVTA may have something here into key lines

144 Replies 12 πŸ‘ 8 πŸ”₯

profile
@singletary #StockTraders.NET
recently

$NVTA may have something here into key lines

130 Replies 12 πŸ‘ 8 πŸ”₯

JO
@John_Seattle #ivtrades
recently

NVTA - LOL - reports quartlery rev of $0.60 per share and loss of $10.87 per share, claim 'double digit growth (15-20%) and stock goes up. 'But losses are less than last quarter' . I needed a smile.

71 Replies 8 πŸ‘ 13 πŸ”₯

profile
@singletary #StockTraders.NET
recently

$NVTA 3.45 still your lvl if stays firm over it let it exhuast

88 Replies 7 πŸ‘ 12 πŸ”₯

profile
@singletary #StockTraders.NET
recently

$NVTA huge stuff wild tape

143 Replies 14 πŸ‘ 15 πŸ”₯

profile
@singletary #StockTraders.NET
recently

$NVTA watching this push

48 Replies 6 πŸ‘ 9 πŸ”₯

profile
@singletary #StockTraders.NET
recently

$NVTA downgraded to underweight at jpm

57 Replies 13 πŸ‘ 6 πŸ”₯

SO
@soheil.n #StockTraders.NET
recently

a push and fail at 4 would be ideal...? > @singletary said: $NVTA faster

111 Replies 15 πŸ‘ 7 πŸ”₯

profile
@singletary #StockTraders.NET
recently

$NVTA faster

103 Replies 9 πŸ‘ 10 πŸ”₯

profile
@achatzi #ivtrades
recently

GM all > @CarlosH said: Cathie Wood's ARK Invest Posts Fund Purchases For Tuesday, Nov. 23, 2021: $ZM, $EXAS, $CRSP, $NVTA, $MTLS, $VLD, $ACHR, $MKFG, $NIU, $MNDY, $GENI, $ROKU, $HOOD, $NNDM, $CND, $VUZI, $ADPT, $PACB, $SDGR, $BFLY, $BNR, $SURF, $DKNG, $STNE, $TOST, $PLTR

106 Replies 6 πŸ‘ 12 πŸ”₯

profile
@CarlosH-carvan #ivtrades
recently

Cathie Wood's ARK Invest Posts Fund Purchases For Tuesday, Nov. 23, 2021: $ZM, $EXAS, $CRSP, $NVTA, $MTLS, $VLD, $ACHR, $MKFG, $NIU, $MNDY, $GENI, $ROKU, $HOOD, $NNDM, $CND, $VUZI, $ADPT, $PACB, $SDGR, $BFLY, $BNR, $SURF, $DKNG, $STNE, $TOST, $PLTR

91 Replies 8 πŸ‘ 12 πŸ”₯

profile
@CarlosH-carvan #ivtrades
recently

hmmm like $NVTA...on watch tomorrow

122 Replies 6 πŸ‘ 14 πŸ”₯

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Healthcare Alkermes ($ALKS) announced that it received notices of partial termination in respect of two license agreements with Janssen Pharmaceutica N.V., a subsidiary of Johnson & Johnson Acadia Pharmaceuticals Inc ($ACAD) 3Q EPS ($0.09) vs est. ($0.26) on sales $131.6Mm vs est. $127.8Mm, says narrows FY Nuplazid sales guide to $480-500Mm Castle Biosciences ($CSTL) 3Q EPS ($0.47) vs est. ($0.41) on revs $23.5Mm vs est. $23Mm; says on track to achieve FY total revs guide of $89-93Mm vs est. $91.9Mm Clover Health ($CLOV) Q3 revs $427.2M vs est. $413.1M, adj EBITDA ($102.3M) vs est. ($99.5M); sees FY revs $1.42B-$1.47B vs est. $1.44B Curaleaf holdings ($CURLF) Q3 revenue $317M vs est. $328.3M, adj EBITDA $71M vs est. $92.1M; remains on track to generate revenue within lower end of $1.2B-$1.3B annual guidance range; said the acquisition of Tryke Companies reported earlier today bolsters its position in NV, AZ, UT and will be immediately accretive to margins and cash flow Fluidigm Corp ($FLDM) 3Q EPS ($0.18) vs est. ($0.22) on revs $28.5Mm vs est. $30Mm; says undertaking review of various options including with regard to strategic alternatives Invitae Corporation ($NVTA) Q3 adj EPS ($0.81) vs est. ($0.71) on revenue $114.4M vs est. $126.5M driven by billable volume 296k (+89% YoY); now sees FY revenue $450M-$475M, from $475M-$500M and below est. $484.5M Mirati Therapeutics, Inc. ($MRTX) 3Q EPS ($1.55) vs est. ($2.89) on revs $71.8Mm Nevro Corp. ($NVRO) Q3 EPS loss ($1.44) vs. est. loss (-$0.87); Q3 rev $93.2M vs. est. $91.59M; sees Q4 revs $94M-$98M Oak Street Health, Inc. ($OSH) Q3 EPS loss (-$0.49) vs. est. loss (-$0.42); Q3 revs $388.7M vs. est. $356.7M; The Company cared for approximately 100,500 risk-based patients, representing 76% of its total patients; adjusted EBITDA was $(64.3M), compared to $(22.8M) YoY SI-BONE ($SIBN) Q3 EPS ($0.48) vs est. ($0.42) on revenue $22.3M vs est. $22.5M, lowered FY21 revenue view to $89M-$90M from $92M-$94M (vs est. $92.7M) as uncertainty surrounding Covid-19’s impact on elective procedures and healthcare infrastructure remains Shockwave Medical ($SWAV) Q3 EPS $0.05 vs. est. loss (-$0.06); Q3 revs $65.2M vs. est. $61.2M; sees FY21 revenue $227M-$228M vs. est. $223.43M, which represents 235% to 236% growth YoY SmileDirectClub, Inc. ($SDC) shares fall -23%; 3Q EPS ($0.23) vs est. ($0.13) on revs $138Mm vs est. $$181Mm; guides FY revs $630-650Mm vs est. $757Mm Tactile Systems ($TCMD) shares fell -12%; 3Q EPS ($0.17) vs est. $0.12 on revs $52.5Mm vs est. $57.4Mm; sees FY revs +9-10% or $203.5M-$206M from $216.3M-$224.5M, below est. +18.7% Merck ($MRK) said the U.S. government will buy 1.4 million additional courses of their COVID-19 pill, molnupiravir, for about $1 bln and that the U.S. has now committed to purchase a total of about 3.1 million courses of molnupiravir for about $2.2 billion Haemonetics ($HAE) Q2 adj EPS $0.60 vs. est. $0.61; Q2 revs $239.9M vs. est. $241.4M; lowers FY22 adj EPS view to $2.40-$2.65 from $2.60-$3.00 and narrows its FY22 revenue view to up 13%-17% from up 13%-18% Technology, Media & Telecom Bandwidth Inc. ($BAND) Q3 adj EPS $0.25 vs. est. $0.08; Q3 revs $130.6M vs. est. $125.3M; guides Q4 EPS loss (15c-11c) vs. est. loss (-$0.01); sees Q4 revs $115.7M-$120.7M vs. est. $125.5M 3D Systems ($DDD) 3Q adj EPS $0.08 vs est. $0.05 on revs $156.1Mm vs est. $144.8Mm; guides FY adj gr mgn 41-43% vs est. 42.7% Five9 Inc. ($FIVN) 3Q adj EPS $0.28 vs est. $0.23 on revs $154.3Mm vs est. $146.8Mm; guides 4Q revs $164.5-165.5mm vs est. $157.8Mm, sees 4Q adj EPS $0.36-0.37 vs est. $0.34; sees FY revs $$600.5-601.5Mm vs est. $585.2Mm and adj EPS $1.09-1.10 vs est. $1.02 Instructure Holdings, Inc. ($INST) 3Q EPS ($0.10) vs est. $0.14 on revs $107.2Mm vs est. $101.1Mm; sees 4Q revs $106.9-107.9Mm vs est. $104.1Mm; guides FY revs $401.7-402.7Mm vs est. $397.4Mm, sees FY adj EBITDA $143.6-144.6Mm vs est. $130Mm Luminar Technologies, Inc. ($LAZR) shares rise 50%; said at the NVIDIA GTC conference that its lidar solution has been selected to be part of the sensor suite in the NVIDIA DRIVE Hyperion autonomous vehicle reference platform. This AI vehicle computing platform accelerates development of autonomous consumer vehicles with planned production starting in 2024. New Relic ($NEWR) Q2 adj EPS loss (10c) vs. est. loss (13c); Q2 revs $196M vss. Est. $182.21M; cuts FY22 adj EPS loss view to (60c)-(54c) from (52c)-(49c) while boosts FY22 revenue view to $778M-$782M from $730M-$735M (est. $736.8M) National CineMedia ($NCMI) Q3 EPS loss (19c) vs. est. loss (13c); Q3 revs $31.7M vs. est. $41.24M; Q3 adjusted OIBDA improved to negative $8.2 million for the third quarter of 2021 from negative $11.2 million for the third quarter of 2020 Roblox ($RBLX) shares rise 29%; Q3 EPS (13c) vs est. (14c) on bookings $637.8M vs est. $636.5M, revenue $509.5M, avg DAUs 47.3M vs est. 46.6M, hours engaged 11.2B (+28% YoY), avg booking per DAU $13.49 Sanmina ($SANM) Q4 adj EPS $0.95 vs. est. $0.99; Q4 revs $1.64B vs. est. $1.7B; sees Q1 adj EPS 90c-$1.00 vs. est. $1.01; sees Q1 revs $1.6B-$1.7B below consensus $1.76B Square Space ($SQSP) Q3 EPS 4c vs est. 14c on revenue $201M vs est. $205.2M; sees Q4 revenue $203M-$206M vs est. $205.2M, raised annual revenue forecast to $780M-$783M from $772M-$780M (est. $778.4M) and unlevered FCF to $117M-$122M from $102M-$116M TripAdvisor ($TRIP) 3Q adj EPS $0.16 vs est. $0.24 on revs $303Mm vs est. $304.4Mm; avg monthly unique users on branded websites rose to about 76% of 2019 comparable period; says CEO will step down during 2022 Vuzix Corporation ($VUZI) Q3 EPS loss (-$0.13), in-line with ests; Q3 revs $3.02M vs. est. $3.79M; General and Administrative expense for the three months ended September 30, 2021 was $3.1 million versus $1.6 million for the comparable 2020 period Xperi Holding Corporation ($XPER) 3Q adj EPS $0.53 vs est. $0.34 on res $219.4Mm vs est. $215.4Mm; guides FY revs $870-890Mm vs est. $882.2Mm Zynga ($ZNGA) 4Q EPS ($0.04) vs est. $0.07 on revs $704.7Mm vs est. $666Mm, qtrly bookings $668Mm +6%, average mobile DAUs 38Mm +21%, qtrly avg mobile MAUs 183Mm +120%; sees FY revs $2.78B vs est. $2.81B, sees FY bookings $2.814B

60 Replies 8 πŸ‘ 8 πŸ”₯

KO
@kooleraid #droscrew
recently

lemon list: $NVTA $TRIP $DDD $LMND

47 Replies 10 πŸ‘ 11 πŸ”₯

Key Metrics

Market Cap

310.20 M

Beta

4.16

Avg. Volume

8.75 M

Shares Outstanding

260.67 M

Yield

0%

Public Float

0

Next Earnings Date

2023-08-09

Next Dividend Date

Company Information

invitae is a genetic information company whose mission is to bring genetic information into routine medical practice to improve the quality of healthcare for billions of people. specializing in genetic diagnostics for hereditary disorders, invitae is aggregating the world’s genetic tests into a single service with better quality, faster turnaround time, and a lower price than most single-gene diagnostic tests today. choose from our curated panels or design your own test for the same low price. today, we are reinventing genetic testing by lowering the barriers for clinicians and patients to obtain diagnostic genetic information. together we can improve healthcare for billions of people.

Website:

HQ: 1400 16th St San Francisco, 94103-5110 California

Related News